Koyfin Home > Directory > Health Care > Akebia Therapeutics > Diluted EPS Excl. Extra Items

Akebia Therapeutics Diluted EPS Excl. Extra Items Chart (AKBA)

Akebia Therapeutics annual/quarterly Diluted EPS Excl. Extra Items from 2012 to 2020. Earnings per share (EPS) is the portion of a company's profit allocated to each outstanding share of common stock. Earnings per share serves as an indicator of a company's profitability. EPS is calculated as: EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.
  • Akebia Therapeutics Diluted EPS Excl. Extra Items for the quarter ending June 06, 2020 was $-1m a 64.23% decrease of -1m year over year
  • Akebia Therapeutics Diluted EPS Excl. Extra Items for the last 12 months ending June 06, 2020 was $-3m a 24.42% decrease of -1m year over year
  • Akebia Therapeutics Annual Diluted EPS Excl. Extra Items for 2019 was $-2m a -4.74% increase of 0m from 2018
  • Akebia Therapeutics Annual Diluted EPS Excl. Extra Items for 2018 was $-2m a 31.55% decrease of -1m from 2017
  • Akebia Therapeutics Annual Diluted EPS Excl. Extra Items for 2017 was $-2m a -112.52% increase of 2m from 2016
Other Per Share Metrics:
  • Akebia Therapeutics Diluted EPS Incl. Extra Items for the quarter ending December 12, 2018 was $-1m a 44.23% decrease of 0m year over year
View Chart On Koyfin

Quarterly AKBA Diluted EPS Excl. Extra Items Data

06/2020$-1m
03/2020$0m
12/2019$-1m
09/2019$0m
06/2019$0m
03/2019$-1m
12/2018$-1m
09/2018$0m
06/2018$-1m
03/2018$0m

Annual AKBA Diluted EPS Excl. Extra Items Data

2019$-2m
2018$-2m
2017$-2m
2016$-4m
2015$-2m
2014$-8m
2013$-127m
2012$-28m
2011$-62m